 Chemotherapy would be used in two phases. In the initial phase all patients would be treated with ICT involving 6 cycles of PCC. This involves Cetuximab 400mgm2 Week 1 and then 250mgm2 weekly, Paclitaxel 80mgm2 weekly and carboplatin AUC 2 weekly for 6 weeks followed by concurrent chemoradiotherapy with cetuximab. After ICT patients would be given weekly Cisplatin at 30mgm2 and cetuximab at 250mgm2 concurrent with radiation therapy. 